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Abstract 16 
Subarachnoid hemorrhage (SAH) is a devastating disease with high rates of mortality and disability 17 
and a poor clinical prognosis. It has been the focus of much attention in both basic and clinical 18 
medical research. Here, we investigate therapeutic drugs and effective targets for early prediction of 19 
SAH. First, we demonstrate that LCN2 can be used to effectively intervene in or treat SAH from a 20 
cell signaling pathway perspective. Next, three potential genes that we explored are validated by 21 
manual review of experimental evidence. Finally, we demonstrate that the ensemble learning model 22 
for early SAH prediction performs better than the classical logistic regression, support vector 23 
machine, and naive-Bayes models. 24 
1 Introduction 25 
Subarachnoid hemorrhage (SAH) is the fastest developing and most critical hemorrhagic 26 
cerebrovascular disease, accounting for 5% of cerebrovascular diseases (Macdonald, 2014), and is 27 
associated with high rates of mortality and disability and poor clinical prognosis (Suarez et al., 2006). 28 
Although there have been significant advances in diagnostic methods, surgery, and endovascular 29 
techniques in recent years, the mortality rate of SAH remains as high as 15% (Macdonald et al., 30 
2008). 31 
The total length of the article is about 3300, including 4 figures in total. 
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Recent research has shown that early brain injury (EBI) may be the main cause of poor prognosis in 32 
SAH patients. Therefore, current SAH studies focus on exploring therapeutic drugs and targets for 33 
reduction of EBI after SAH and the early prediction of SAH (Sozen et al., 2011).  34 
Lipocalin 2 (LCN2) is an acute secretory protein that regulates the pathophysiological processes of 35 
various organ systems in mammals and participates in the intrinsic immune protection of the central 36 
nervous system (CNS) (Flo et al., 2004;Ferreira et al., 2015). Studies of acute white matter injury in a 37 
mouse SAH model and the role of LCN2 in injury (Egashira et al., 2014) indicate that LCN2 plays an 38 
important part in SAH-induced white matter injury. Since above evidences suggest that LCN2 is 39 
closely related to SAH, we propose our first research question: is specific intervention for LCN2 40 
(Warszawska et al., 2013) a promising SAH treatment strategy?  41 
On the other hand, most previous studies (Chu et al., 2011;Ni et al., 2011;Zhang et al., 2017a) have 42 
only explored biomarkers for SAH prediction and treatment in a narrow molecular range, rather than 43 
taking a genome-wide approach. We propose our second research question: could we use a genome-44 
wide approach to find potential biomarkers for SAH based on the effects of LCN2 treatment?  45 
Previous studies have usually predicted SAH based on diagnostic imaging (Frontera et al., 46 
2006;Ramos et al., 2019) and clinical automation data (Roederer et al., 2014), which may not provide 47 
enough predictive power. Thus, we propose our third research question: could we use key genes to 48 
build a more powerful early prediction model for SAH? 49 
In this paper, we propose a new research plan to answer the above three research questions. First, we 50 
use SAH intervention experiments to screen out candidate genes that are susceptible to LCN2, then 51 
employ Fisher’s exact test (Xie et al., 2011;Li et al., 2017;Xia et al., 2017;Zhang et al., 2019b) to 52 
choose signaling pathways from among the candidates under different experimental conditions. 53 
Second, we use e-Bayes (Carlin and Louis, 2010), SVM-RFE (Duan et al., 2005), SPCA (Zou et al., 54 
2006), and statistical tests (Zhang et al., 2016;Zhang et al., 2018;Xiao et al., 2019b;Zhang et al., 55 
2019b;Zhang et al., 2019d;Zhang et al., 2020) to investigate key genes from experimental data by 56 
considering both SAH and LCN2 as factors. Third, we integrate the logistic regression (LR), support 57 
vector machine (SVM), and naive-Bayes algorithms (Xia et al., 2017;Zhang et al., 2017a;Zhang et 58 
al., 2019a) into an ensemble learning model (Gao et al., 2017;Zhang et al., 2019b) to build a model 59 
for early SAH prediction.  60 
First, manual review of the experimental evidence (Osuka et al., 2006;Majdalawieh et al., 61 
2007;Hanafy et al., 2010;Hao et al., 2014;Kwon et al., 2015;Yu et al., 2018) demonstrates that we 62 
could intervene or treat SAH by targeting LCN2 from a cell signaling pathway perspective. Next, we 63 
explore three key genes that are sensitive to both SAH and LCN2 treatment, again using manual 64 
review of the experimental evidence (Huang et al., 2016;Sabo et al., 2017;Yu et al., 2018) to cross-65 
validate the relationships between SAH and these key genes. Finally, we show that our SAH early 66 
prediction ensemble-learning model outperforms the classical LR, naive-Bayes, and SVM models. In 67 
summary, we consider that this work provides a novel strategy for the future study of clinical 68 
treatment of SAH and related diseases. 69 
2 Materials and Methods 70 
2.1 Experimental configuration 71 
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All experimental procedures were approved by the Ethics Committee of Southwest Hospital and 72 
were performed in accordance with the guidelines of the National Institutes of Health Guide for the 73 
Care and Use of Laboratory Animals. 74 
2.1.1 Intervention experiment for SAH 75 
The original chip data for this experiment were provided by the Department of Neurosurgery, 76 
Southwest Hospital, PLA Military Medical University. SAH and sham-operated models were 77 
established; details are given in the Supplementary Material. Each experimental group included five 78 
mice, and the white matter area of the cerebral cortex was taken for gene chip testing. A total of 10 79 
original chip samples were obtained from the SAH intervention experiments; these were divided 80 
equally into two groups as follows. 81 
(1) SAH disease group: brain tissue in the white matter region of the cerebral cortex of SAH mice.  82 
(2) Control group normal-1: brain tissue in the white matter region of the cerebral cortex of normal 83 
mice. 84 
The chip was an Affymetrix GeneChip Mouse Gene 1.0 ST Array. Raw data included sample RNA 85 
extraction (white matter brain cells from the SAH model and from normal mice), sample RNA 86 
quality detection (total RNA>1 ug), cDNA synthesis, sense strand cDNA fragmentation, biotin 87 
labeling, chip hybridization, chip elution, and chip scanning. The raw data are available at 88 
http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8407. 89 
We then carried out mass analysis and used the R Bioconductor package to perform quality control 90 
for each original chip (the SAH disease group and the control group normal-1). In the output gray 91 
scale image (Figure S1) for each chip sample, each chip name and the four corner patterns were very 92 
clear, and the contrast between light and dark was moderate.  93 
The right panel of Figure 1A shows the Relative Log Expression (RLE) boxplot for these 10 chips. 94 
The center of each sample was close to the position RLE=0. This indicates that the expression levels 95 
of most genes in the sample were consistent. In addition, Figure S2 describes a normalized unscaled 96 
standard errors (NUSE) detection(Marta and Marc, 2014). Since Figure S2 shows that the center of 97 
each sample is close to the position NUSE=1, we consider that the samples are too stable to have 98 
obvious batch effect. Then, we used Robust Multi-chip Analysis (RMA) (Irizarry et al., 2003) for 99 
data preprocessing, including background and perfect match probes (PM) correction, normalization, 100 
and summarization, to obtain the probe expression data matrix (Table S1). Finally, clustering 101 
analysis(Liu et al., 2019;Xiao et al., 2019a;ZHANG et al., 2019c;Wu and Zhang, 2020) (Figure S3) 102 
shows that the major differences between the chip of each group comes from SAH. 103 
2.1.2 Intervention experiment for LCN2 104 
Here, in order to interfere with the expression of LCN2, 2 μL of specific short interfering RNAs 105 
(siRNAs) was delivered into the lateral ventricle with a Hamilton syringe. The injection was 106 
performed 48 h before SAH and three groups were used, as described below. We detail the 107 
procedures in the Supplementary Material. 108 
 (1) SAH-siRNA-LCN2: the SAH model was established and treated with intrathecal injection of 109 
LCN2 siRNA, and two samples were taken on the first and third days after surgery.  110 
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(2) SAH-siRNA-NC: the SAH model was established and treated with intrathecal NC siRNA, and 111 
two samples were taken on the first and third days after surgery, which helped us to remove the 112 
interference factors associated with the siRNA vector.  113 
(3) Control group normal-2: the brain tissue of the white matter region of the cerebral cortex without 114 
any treatment.  115 
The total number of samples in all experiments was 25 (Table 1). RNA sequencing was performed on 116 
the samples and the raw data are available at https://www.ncbi.nlm.nih.gov/sra/PRJNA575372.  117 
Table 1 118 
2.2 Workflow of the study 119 
Figure 1  120 
The workflow of the study is illustrated in Figure 1. First, we designed the intervention experiment 121 
for SAH detailed in section 2.1.1, which allowed us to obtain the differential genes under different 122 
experimental conditions. Based on these differential genes, we could identify the key signaling 123 
pathways.  124 
As targeting LCN2 could result in changes in these related signaling pathways (causing remission or 125 
promotion of SAH), we consider that LCN2 plays an important part in the entire biological cell 126 
process for SAH.  127 
Next, we used an intervention experiment for LCN2 to obtain gene expression levels for diseased and 128 
normal mouse brain cells at different time points. Then, we employed commonly used dimensional 129 
reduction algorithms to explore three key genes under the impact of both SAH and LCN2 treatment.  130 
Finally, we used these three key genes as classifiers to develop an ensemble learning model for early 131 
SAH prediction, the predictive power of which was much better than that of the classic LR, naive-132 
Bayes, and SVM models.  133 
3 Results  134 
3.1 Signaling pathway analysis 135 
3.1.1 Differentially expressed gene selection 136 
We used e-Bayes, one of the most commonly used methods for differential expression analysis 137 
(Edwards et al., 2005), to screen the differential genes by setting Fold change ≥ 1.5 and p-value <138 
0.05. Table S2 lists 2942 differentially expressed genes, accounting for 10.16% of the total number 139 
of genes (28,944). Among them, there were 1016 and 1926 genes with upregulated and 140 
downregulated expression (Figure S4), respectively. 141 
3.1.2 Pathway analysis  142 
We used Eq. 1 and the data in Table S3 to explore related signaling pathways by carrying out 143 
Fisher’s exact test (Xia et al., 2017) using Kobas 3.0 (Wu et al., 2006;Xie et al., 2011;Ai et al., 2018) 144 
for the differentially expressed genes from Table S2. 145 
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Here, 𝑁 is the number of genes in the sample and 𝑛 is the number of genes contained in the 147 
pathway. 𝑁𝑓 is the number of differentially expressed genes and 𝑛𝑓 is the number of differentially 148 
expressed genes included in the pathway.  149 
The Fisher’s exact test assumes 𝐻0: 𝑝1 = 𝑝2; the alternative hypothesis is 𝐻1: 𝑝1 ≠ 𝑝2. 𝑝1is the 150 
probability that the differentially expressed gene will fall in the pathway, and 𝑝2 is the probability 151 
that the non-differentiated gene does not fall in the pathway. The p-value (𝑝𝐹) of Fisher’s exact test 152 
was obtained by Eq. 1. 153 
Table S2 lists 70 signaling pathways for which the p-value was less than 0.001. LCN2 is a protein 154 
involved in MAPK signaling pathways that protects the CNS as part of the innate immune system 155 
(Warszawska et al., 2013). Previous studies have shown that LCN2 activates phosphorylation of p38 156 
MAPK, which phosphorylates the Ser168 and Ser170 sites of NFATc4 and inhibits nuclear 157 
translocation of NFATc4 (Olabisi et al., 2008). NFATc4 is a key factor in remyelination and closely 158 
related to SAH, indicating that white matter damage after SAH is associated with remyelination (Kao 159 
et al., 2009;Guo et al., 2017).  160 
Therefore, we hypothesize that LCN2 could promote the phosphorylation of transcription factor 161 
NFATc4 and inhibit its nuclear transcription by activating p38 MAPK, thereby preventing 162 
remyelination and causing white matter damage after SAH. 163 
3.1.3 LCN2 intervention experimental results analysis 164 
To prove our hypothesis, we designed a LCN2 intervention experiment (Figure 1B) to test whether 165 
LCN2 could affect SAH from the perspective of the differential expressed genes and the related 166 
signaling pathways.  167 
First, we used the DESeq2 (Varet et al., 2016) method to select differentially expressed genes from 168 
SAH-siRNA-LCN2 and normal-2, SAH-siRNA-NC and normal-2, and SAH-siRNA-LCN2 and 169 
SAH-siRNA-NC groups on days 1 and 3, respectively(Table 1). The results are shown in Table 2, 170 
Table S4, and Figure S5. 171 
Table 2 172 
Next, we used Kobas 3.0 (Wu et al., 2006;Xie et al., 2011;Ai et al., 2018) to carry out Fisher’s exact 173 
test for the differential genes in Table 2, to identify related signaling pathways (Table S5). Next, we 174 
used the manually reviewed evidence (Osuka et al., 2006;Majdalawieh et al., 2007;Hanafy et al., 175 
2010;Hao et al., 2014;Kwon et al., 2015;Yu et al., 2018) to cross-validate the SAH-related signaling 176 
pathways in Table S5. Table 3 lists the cross-validated SAH-related signaling pathways.  177 
Table 3 178 
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As shown in Table 3, all the experimental groups had SAH-related signaling pathways except the 179 
transcriptional misregulation in cancer signaling pathway (Lee and Young, 2013) in the SAH-180 
siRNA-LCN2 (3 day) vs SAH-siRNA-NC (3 day) experimental group. However, as one of the 181 
proteins from this pathway, Gzmb (Table S5), is closely associated with post-ischemic brain cell 182 
death (Chaitanya et al., 2010), we consider that it could be a new target for secondary brain injury 183 
inhibition (Armstrong et al., 2017). Therefore, we conclude that specific intervention for LCN2 is a 184 
promising SAH treatment strategy. 185 
3.2 Feature selection 186 
After demonstrating the impact of LCN2 on SAH, we chose potential biomarkers for SAH using a 187 
genome-wide approach. Figure 1C shows the workflow used to choose key genes that were not only 188 
related to both SAH and LCN2 but were also insensitive to treatment at different time points. Figure 189 
1C shows the following three modules.  190 
(1) SAH intervention experiment module  191 
Owing to the large number of differential genes (Table S2), it was necessary to further narrow down 192 
the scope of the screening. First, we used the e-Bayes method (Edwards et al., 2005) to filter the 193 
probe expression data matrix (Table S1) by the e-Bayes function of R’s limma package (Smyth, 194 
2005). The differential probes were obtained by setting the filter parameters to Fold change ≥ 2 and 195 
p-value < 0.05. 196 
Second, we used SVM-RFE (Duan et al., 2005) (Eq. 2) to rank the genes in the probe expression data 197 
matrix, and then carried out the t-test and F-test (Zhang et al., 2017b) for the top 100 genes. 198 
{
𝑫𝑱(𝒊) = (𝟏/𝟐)𝜶𝑻𝑯𝜶 − (𝟏/𝟐)𝜶𝑻𝑯(−𝒊)𝜶
𝑯 = 𝒚𝒊𝒚𝒋𝑲(𝒙𝒊, 𝒙𝒋)
 
(2) 
where 𝑦𝑖 and 𝑦𝑗 represent the classification labels of probes 𝑥𝑖 and 𝑥𝑗, respectively; 𝐾(𝑥𝑖 , 𝑥𝑗) is the 199 
kernel function, 𝑖, 𝑗 = 1,2, … , 𝑛;  𝛼 is obtained by training the SVM classifier; 𝐷𝐽(𝑖) is the sort 200 
function; and H is the matrix.  201 
We then combined the results of these two methods to obtain the significant probes for both the e-202 
Bayes and SVM-RFE methods.  203 
Finally, we used the transcription cluster annotation file (version: MoGene-1_0-st-v1) downloaded 204 
from the Affy (Gautier et al., 2004) website to extract the gene ID for these probes, resulting in 47 205 
key genes (Table S6).  206 
(2) LCN2 intervention experiment module 207 
We performed t-tests and F-tests (Zhang et al., 2017b) for the key genes (Table S6) in the SAH-208 
siRNA-LCN2 (1 day) vs normal-2 and SAH siRNA-LCN2 (3 day) vs normal-2 groups (Table S4). 209 
There were 15 and 13 statistically significantly differential genes for the SAH-siRNA-LCN2 (1 day) 210 
vs normal-2 group (Table S7) and the SAH-siRNA-LCN2 (3 day) vs normal-2 group (Table S8), 211 
respectively. Taking the intersection of the results from these two experimental groups gave nine key 212 
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genes, Tk1, Cyr61, Nupr1, Dcn, Lum, Olig1, Pcolce2, Slc6a9, and Kcnt2, which were sensitive to 213 
both SAH and LCN2 intervention, regardless of treatment, at different time points. 214 
(3) Dimensional reduction module  215 
Next, we employed the SPCA algorithm (Zou et al., 2006;Li et al., 2017) to perform dimensional 216 
reduction for the nine key genes. This resulted in five candidate genes (Tk1, Cyr61, Olig1, Slc6a9, 217 
and Pcolce2). However, manual review of the experimental evidence indicated that only Cyr61 (Yu 218 
et al., 2018), Olig1 (Sabo et al., 2017), and Slc6a9 (Huang et al., 2016) were closely related to SAH, 219 
cerebral hemorrhage, and brain injury. Therefore, we considered these three genes (Figure 2, Table 220 
S9) to be potential biomarkers for SAH. 221 
Figure 2 222 
3.3 Ensemble learning model 223 
3.3.1 Early SAH prediction model 224 
This study used three classification algorithms, LR (Hosmer Jr et al., 2013), SVM (Suykens and 225 
Vandewalle, 1999), and naive-Bayes (Wang et al., 2007) to develop the SAH prediction model, using 226 
the selected key genes as the respective classifiers. These three classic methods were then integrated 227 
into a novel ensemble learning model to improve the predictive accuracy.  228 
Figure 3 shows the workflow of the SAH prediction model, based on our previous studies (Li et al., 229 
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𝒀(𝒙) = {
𝟏    𝑬𝑯𝒎 ≥ 𝟎. 𝟓
𝟎    𝑬𝑯𝒎 < 𝟎. 𝟓
 
(9) 
Here, 𝐷𝑡(𝑖) is the weight distribution, t is the iteration time, 𝑖 is the index of the sample, and n is the 231 
number of the sample. ε𝑡 and α𝑡 are the error rate and weight of each weak classifier ℎ𝑡, respectively. 232 
For a sample set 𝑆 = {(𝑥1, 𝑦1), (𝑥2, 𝑦2), … , (𝑥𝑛, 𝑦𝑛) }, 𝑥𝑛 are the samples and 𝑦𝑛 ∈ {0,1} are the 233 
labels; 𝑦𝑖=0 indicates that 𝑥𝑖 is not an SAH patient, and 𝑦𝑖=1 indicates that 𝑥𝑖 is an SAH patient. 𝐻𝑚 234 
is the homomorphic integration for each weak classifier ℎ𝑡; m is the index of the weak classifier, 235 
m=1,2,3; 𝑇 is the threshold of the iteration time; 𝑃𝐻𝑚 is the predictive probability of disease; and 236 
𝐸𝐻𝑚is the estimated probability of the model 𝐻𝑚. 𝑌(𝑥) is the result of the final classifier obtained by 237 
a voting method (Dietterich, 2000). 238 
Figure 3 239 
3.3.2 Predictive performance comparison 240 
Figure 4A compares the classification performance for the LR, naive-Bayes, SVM, and ensemble 241 
learning models, based on four commonly used classification measurements (Table S10) (Zhang et 242 
al., 2019b). The numerical values used in Figure 4A are listed in Table S11; these demonstrate that 243 
the ensemble learning method outperforms the other three methods with respect to accuracy, 244 
precision, sensitivity and specificity. The ROC chart plotted in Figure 4B compares the classification 245 
effects of LR, Naive Bayes, SVM, and ensemble learning models. The classification effect of 246 
ensemble learning models is also superior to the other three. 247 
Figure 4 248 
4 Discussion 249 
This study aimed to interrogate the potential therapeutic targets of SAH and use them as classifiers to 250 
develop a model for early prediction of SAH.  251 
To achieve this aim, we proposed the following three scientific questions. First, is specific 252 
intervention involving LCN2 a promising SAH treatment strategy? Second, could we choose 253 
potential biomarkers for SAH at a genome-wide level by considering the effects of LCN2? Third, 254 
could we use key genes to build an SAH early prediction model with strong predictive power? 255 
Regarding the first question, as the manually reviewed experimental evidence (Osuka et al., 256 
2006;Majdalawieh et al., 2007;Hanafy et al., 2010;Hao et al., 2014;Kwon et al., 2015;Yu et al., 2018) 257 
and the results in Table 3 all indicate that LCN2-related signaling pathways play an important part in 258 
the pathogenesis SAH, we propose that LCN2 could promote or alleviate SAH-related diseases, and 259 
could also be used to treat SAH in the future. 260 
To answer the second question, we used mathematical algorithms to explore five potential gene 261 
biomarkers (Tk1, Cyr61, Olig1, Slc6a9, and Pcolce2), considering the impact of both SAH and 262 
LCN2 treatment at different time points, and also used the manually reviewed experimental evidence 263 
to demonstrate that Cyr61 (Yu et al., 2018), Olig1 (Sabo et al., 2017), and Slc6a9 (Huang et al., 264 
2016) were closely related to SAH. Although Tk1 and Pcolce2 have not been reported to be 265 
associated with SAH, we will investigate their connections in future work.  266 
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Regarding the third question, although this study represents significant progress in SAH prediction, it 267 
had several drawbacks. For example, the SAH intervention experiment sample size was too small for 268 
us to demonstrate high predictive accuracy for the model. In future work, we will integrate more 269 
recent bioinformatics research algorithms (Zhang et al., 2016;Gao et al., 2017;Zhang et al., 270 
2017a;Zhang and Zhang, 2017;Zhang et al., 2018;Zhang et al., 2019a;Zhang et al., 2019d) and data 271 
into the system to overcome the problems. 272 
In summary, this study analyzed the impact of LCN2 on SAH and explored the key biomarkers of 273 
SAH under LCN2 treatment at different time points. An ensemble learning model was developed to 274 
predict SAH occurrence. The results demonstrate that LCN2 (Warszawska et al., 2013) can 275 
effectively intervene in or treat SAH from a cell signaling pathway perspective. Also, three key genes 276 
were identified and validated by manual review of the experimental evidence (Huang et al., 277 
2016;Sabo et al., 2017;Yu et al., 2018). Finally, the results showed that the ensemble learning model 278 
performed better for early SAH prediction than the classical LR, SVM, and naive-Bayes models. 279 
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TABLE AND FIGURES LEGENDS 463 
Figure 1. Workflow of the study. (A) SAH intervention experimental chip RLE box line diagram; 464 
the abscissa is log_2 (Median value of sample expression) and the ordinate represents each chip; (B) 465 
The volcano map of the comparison group SAH-siRNA-NC (1 day) vs normal-2. The abscissa is 466 
𝑙𝑜𝑔2(𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒) and the ordinate is −𝑙𝑜𝑔10(𝐹𝐷𝑅) ; The red point is the up-regulated gene, the 467 
blue point is the down-regulated gene, and the non-dispersive point is the non-differentiated gene; 468 
(C) Key gene screening workflow; (D) The accuracy for ensemble learning, LR, SVM and Naive-469 
Bayes. 470 
Figure 2. Venn plot for the key genes 471 
Figure 3. SAH predictive ensemble learning model  472 
Figure 4. Model performance. (A) Comparison of classification performance of LR, SVM , Naive-473 
Bayes and ensemble learning model; (B) ROC chart plotted for LR, SVM , Naive-Bayes and 474 
ensemble learning model. 475 
 476 
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Table 1. Experimental sample description after LCN2 intervention experiment. 478 
Sample Number of samples Description 
SAH-siRNA-
LCN2(1day) 
5 Mouse (SAH) brain cells, Intrathecal 




Mouse (SAH) brain cells, Intrathecal 
injection of LCN2 siRNA for 3 day 
SAH-siRNA-
NC(1day) 
5 Mouse (SAH) brain cells, Intrathecal 




Mouse (SAH) brain cells, Intrathecal 
injection of blank siRNA for 3 day 
normal-2 5 
Mouse (normal) brain cells, blank 
control group-2 
 479 
  480 
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SAH-siRNA-LCN2(1day) VS normal-2 25342 1541 634 
SAH-siRNA-LCN2 (3day) VS normal-
2 
25055 1264 451 
SAH-siRNA-NC(1day) VS normal-2 25384 1159 556 
SAH-siRNA-NC(3day) VS normal-2 25564 1297 409 
SAH-siRNA- LCN2 (1day) VS SAH-
siRNA-NC(1day) 
25293 99 14 
SAH-siRNA- LCN2 (3day) VS SAH-
siRNA-NC(3day) 
25251 5 18 
 482 
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Table 3. Cross-validated SAH related signaling pathway. 484 
Experimental group Important pathways related to SAH 
SAH-siRNA-LCN2(1day) VS 
normal-2 
PI3K-Akt(Hao et al., 2014), Jak-STAT(Osuka et al., 2006), 
p53(Yu et al., 2018), TNF(Hanafy et al., 2010), Toll-like 
receptor(Kwon et al., 2015), NF-
kappaβ(Majdalawieh et al. , 2007) 
SAH-siRNA-LCN2 (3day) VS 
normal-2 
PI3K-Akt(Hao et al., 2014), Jak-STAT(Osuka et al., 2006), 
p53(Yu et al., 2018), TNF(Hanafy et al., 2010), Toll-like 
receptor(Kwon et al., 2015), NF-
kappaβ(Majdalawieh et al. , 2007) 
SAH-siRNA-NC(1day) VS 
normal-2 
PI3K-Akt(Hao et al., 2014), Jak-STAT(Osuka et al., 2006), 
TNF(Hanafy et al., 2010), Toll-like receptor(Kwon et al., 
2015), NF-kappaβ(Majdalawieh et al. , 2007) 
SAH-siRNA-NC(3day) VS 
normal-2 
PI3K-Akt(Hao et al., 2014), Jak-STAT(Osuka et al., 2006), 
TNF(Hanafy et al., 2010), Toll-like receptor(Kwon et al., 
2015), NF-kappaβ(Majdalawieh et al. , 2007) 
SAH-siRNA- LCN2 (1day) VS 
SAH-siRNA-NC(1day) 
TNF(Hanafy et al., 2010), Toll-like receptor(Kwon et al., 
2015) 
SAH-siRNA- LCN2 (3day) VS 
SAH-siRNA-NC(3day) 
Transcriptional misregulation in cancer(Lee and Young, 
2013) 
 485 
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1 Supplementary Figures and Tables 
1.1 Supplementary Figures 
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Figure S1. Gray scale image for SAH intervention experiment. Ten original chip gray scale 
images of SAH intervention experiment; (A)-(E) are the gray scale images for five experimental 




Figure S2. SAH intervention experimental chip NUSE boxplot.  
 
Figure S3. Cluster graph for SAH intervention experiment.  
  Supplementary Material 
 4 
 
Figure S4. Volcanic maps for SAH intervention experiment. The volcano map of the comparison 
group SAH vs normal-1. The abscissa is 𝑙𝑜𝑔2(𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒) and the ordinate is −𝑙𝑜𝑔10(𝐹𝐷𝑅). The 
red, green and non-dispersive points represent the up-regulated, down-regulated, and non-




Figure S5. Volcanic maps for LCN2 intervention experiment. The volcano map of the different 
group. The abscissa is 𝑙𝑜𝑔2(𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒) and the ordinate is −𝑙𝑜𝑔10(𝐹𝐷𝑅). The red, blue and non-
dispersive points represent the up-regulated, down-regulated, and non-differentiated gene, 
respectively. 
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1.2  Supplementary Tables 
Table S1. Probes expression data matrix. 
The experimental probe expression matrix for each group in the SAH intervention experiment. 
 
Table S2. SAH intervention experiment analysis results. 
The results of differentially expressed gene analysis and related signaling pathway analysis in SAH 
intervention experiments. 
 






Included in pathway 𝑛𝑓 𝑛 − 𝑛𝑓 𝑛 
Not included in pathway 𝑁𝑓 − 𝑛𝑓 (𝑁 − 𝑛𝑓) − (𝑛 − 𝑛𝑓) 𝑁 − 𝑛 
Total 𝑁𝑓 𝑁 − 𝑁𝑓 𝑁 
 
Table S4. Differential genetic analysis results for LCN2 interventional experiments. 
Results of differential genetic analysis for each group of data in the LCN2 intervention experiment. 
 
Table S5. Signaling pathway analysis results for LCN2 intervention experiments. 
Results of signaling pathway analysis of each group of data in the LCN2 intervention experiment. 
 
TableS1, S2, S4 and S5 are available on https://github.com/charlotte5683/supplementary-of-
SAH.git. 
 































Table S7. Significantly differential genes for SAH-siRNA-LCN2(1day) VS normal-2 group. 










Table S8. Significantly differential genes for SAH-siRNA-LCN2(3day) VS normal-2 group. 












Table S9. Input samples for the prediction model. 
Gene Name SAH_1 SAH_2 SAH_3 SAH_4 SAH_5 
Cyr61 5.8942628 5.96110867 5.93479255 6.02621404 5.73609078 
Olig1 7.0429023 7.56910104 7.21385307 7.27041593 7.43777252 
Slc6a9 9.4912445 9.20928367 9.54588542 9.43792448 9.01581096 
Gene Name Normal-1_1 Normal-1_2 Normal-1_3 Normal-1_4 Normal-1_5 
Cyr61 
7.3059794 7.56463002 7.19854145 7.74025933 7.38489239 
Olig1 
8.8771356 9.18547761 8.8943184 9.011647 8.88975631 
Slc6a9 
7.1622279 7.28458596 7.34258084 7.42990633 7.09533177 
 
Table S10. Model performance indicator. 











TN: not actually diseased and is 
recognized as a disease 






FP： not actually affected, but it is 





FN: actual illness, but was identified as 
being unaffected 
 
Table S11. Model performance statistic. 
 LR SVM Naive-Bayes Ensemble 
Accuracy 0.612500±0.074789 0.518750±0.035013 0.497917±0.058101 0.789583±0.108943 
Precision 0.660069±0.155874 0.527778±0.139916 0.565625±0.135964 0.765104±0.141375 
Sensitivity 0.631944±0.160185 0.621528±0.167532 0.729167±0.127047 0.87500±0.105263 
Specificity 0.656250±0.227961 0.510417±0.252522 0.500000±0.252632 0.770833±0.178509 
 
2 Supplementary Note 
2.1 SAH intervention experiment 
The mouse endovascular perforation model of SAH was induced as reported previously(Yujie et al., 
2015;Amp and Wilkins, 2017). Briefly, mice were anesthetized with isoflurane. A sharpened 5-0 
monofilament nylon suture was inserted rostrally into the left internal carotid artery from the external 
carotid artery stump and perforated the bifurcation of the anterior and middle cerebral arteries. Sham-
operated mice underwent the same procedure without puncturing the artery. Tissues of white matters 
were taken for follow-up detection on day 3 after SAH. 
The processed datasets for this study can be found in the github: 
 https://github.com/charlotte5683/SAH.git 
ArrayExpress accession:  E-MTAB-8407  
https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8407/ 
2.2 LCN2 intervention experiment  
According to methods described previously (Zuo et al., 2017), an intracerebroventricular injection was 
performed. Put simply, mice were placed on a stereotaxic apparatus (Rwdmall, Guangzhou, China) 
after anesthetized with 2% pentobarbital sodium (50 mg/kg, intraperitoneal). The bregma point was 
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then exposed and a small bone window was drilled into the bone of the left hemisphere. Then, 2 μL 
specific siRNAs was delivered into the lateral ventricle with a Hamilton syringe (Hamilton Company, 
Reno, NV, USA). The injection was performed 48 h before SAH. Tissues of white matters were taken 
for follow-up detection on day 1 and day 3 after SAH respectively. 
The processed datasets for this study can be found in the github: 
https://github.com/charlotte5683/LCN2.git 
NCBI SRA accession: PRJNA575372    
 https://www.ncbi.nlm.nih.gov/sra/PRJNA575372 
 
2.3 Code availability  
Code used for predictive model is available at https://github.com/charlotte5683/SAH-code . 
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